ROLIMUS 10MG

Rolimus 10mg tablet is an antineoplastic medication classified as an mTOR kinase inhibitor, with everolimus as its active ingredient. It is indicated for the treatment of advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumors, and subependymal giant cell astrocytoma (tumors located in the brain’s ventricles). Maintaining good oral hygiene and attending regular dental check-ups is crucial during treatment, as this medication may lead to mouth sores or ulcers. It is frequently used in conjunction with cyclophosphamide, an alkylating agent, for the management of subependymal giant cell astrocytoma.

Prior to commencing this medication, it is essential to understand that the risk of bacterial or viral infections may increase. If you have a history of Hepatitis B, the Rolimus 10mg tablet may heighten the risk of reinfection. Notify your healthcare provider if you experience symptoms such as fever, chills, cough, jaundice, joint pain, or swelling while undergoing treatment. It is advisable to minimize exposure to sunlight and UV light by wearing protective clothing and applying sunscreen regularly, as this medication may elevate the risk of developing cancers. Additionally, avoid consuming grapefruit juice or grapefruit during the course of treatment.

This tablet is not suitable for adolescents and children under 18 years of age. Seek immediate medical attention if you experience shortness of breath, chest pain, or a worsening cough. Throughout the treatment with Rolimus 10mg tablet, your physician may periodically assess your white blood cell counts, platelets, blood sugar levels, electrolytes, and kidney function to avert serious complications. This medication carries the risk of causing kidney issues. Inform your doctor if you have a history of liver disorders, heart failure, high cholesterol, or hypertension before initiating treatment. It is also important to avoid live vaccines and limit contact with individuals who have received live vaccines.